Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525707 (US11174250, Example 125) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 49 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525675 (US11174250, Example 93) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 197 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525693 (US11174250, Example 111) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 203 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525589 (US11174250, Example 7) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 216 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525628 (US11174250, Example 46) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525706 (US11174250, Example 124) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 293 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525582 (US11174250, Example 32 | US11174250, Example Table...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 332 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525627 (US11174250, Example 45) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 514 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525609 (US11174250, Example 27) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 529 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525664 (US11174250, Example 82) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 549 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525578 (US11174250, Example 73 | US11174250, Example Table...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 592 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525578 (US11174250, Example 73 | US11174250, Example Table...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 592 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525692 (US11174250, Example 110) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 607 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525583 (US11174250, Example 1) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 764 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525608 (US11174250, Example 26) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 779 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525659 (US11174250, Example 77) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 907 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525575 (US11174250, Example 2 | US11174250, Example Table4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 939 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525575 (US11174250, Example 2 | US11174250, Example Table4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 939 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525575 (US11174250, Example 2 | US11174250, Example Table4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 939 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525585 (US11174250, Example 3) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 966 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525672 (US11174250, Example 90) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525648 (US11174250, Example 66) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525652 (US11174250, Example 70) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525649 (US11174250, Example 67) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525619 (US11174250, Example 37) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525642 (US11174250, Example 60) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.41E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525598 (US11174250, Example 16) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525590 (US11174250, Example 8) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.48E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525631 (US11174250, Example 49) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.57E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525613 (US11174250, Example 31) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525656 (US11174250, Example 74) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.75E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525632 (US11174250, Example 50) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.79E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525650 (US11174250, Example 68) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525581 (US11174250, Example 116 | US11174250, Example Tabl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525658 (US11174250, Example 76) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525653 (US11174250, Example 71) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.07E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525657 (US11174250, Example 75) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.09E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525695 (US11174250, Example 113) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525597 (US11174250, Example 15) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525624 (US11174250, Example 42) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.28E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525617 (US11174250, Example 35) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525629 (US11174250, Example 47) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.39E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525621 (US11174250, Example 39) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525588 (US11174250, Example 6) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.51E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525678 (US11174250, Example 96) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.53E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525651 (US11174250, Example 69) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525625 (US11174250, Example 43) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.25E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525669 (US11174250, Example 87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.89E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525681 (US11174250, Example 99) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
P61964[22-334]/Q03164[3745-3969]/Q15291/Q9C005/Q9UBL3[2-534] (Human-Homo sapiens (Human)) | BDBM525620 (US11174250, Example 38) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.99E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compound potency was assessed through incorporation of 3H-SAM into oligonucleosomes purified from HeLa cells. Specifically, recombinant human MLL1 (a... | Citation and Details BindingDB Entry DOI: 10.7270/Q2C53Q0K | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 72 total ) | Next | Last >> |